外科理论与实践

外科理论与实践 >

2022 , Vol. 27 >Issue 03: 266 - 270

DOI: https://doi.org/10.16139/j.1007-9610.2022.03.017

综述

局部进展期结肠癌病人的新辅助治疗

展开
  • 上海交通大学医学院附属瑞金医院外科 上海市微创外科临床医学中心,上海 200025

收稿日期: 2020-12-03

  网络出版日期: 2022-08-03

收起

Neoadjuvant therapy in patients with locally advanced colon cancer

Expand
  • Department of Surgery, Ruijin Hospital,Shanghai Jiao Tong University School of Medicine, Shanghai Minimally Invasive Surgery Center, Shanghai 200025, China

Received date: 2020-12-03

  Online published: 2022-08-03

Fold

摘要

局部进展期结肠癌（locally advanced colon cancer, LACC）的新辅助治疗仍不明确。为进一步提高LACC病人的生存率,本文总结新辅助化疗、新辅助化疗联合靶向治疗以及放、化疗联合治疗LACC,重点是安全性和有效性。

关键词： 结肠癌; 局部进展期; 新辅助治疗

本文引用格式

许梓枫 综述, 宗雅萍, 陆爱国 审校 . 局部进展期结肠癌病人的新辅助治疗[J]. 外科理论与实践, 2022 , 27(03) : 266 -270 . DOI: 10.16139/j.1007-9610.2022.03.017

Abstract

It is still unclear about neoadjuvant therapy in patients with locally advanced colon cancer (LACC). This review summarized neoadjuvant chemotherapy, neoadjuvant chemotherapy combined with targeted therapy and combined radio-chemotherapy for the patients with LACC to increase the survival of patients focusing on the efficacy and safety of neoadjuvant therapy.

Key words： Colon cancer; Locally advanced stage; Neoadjuvant therapy

参考文献

[1] Mármol I, Sánchez-de-Diego C, Pradilla Dieste A, et al. Colorectal carcinoma: a general overview and future perspectives in colorectal cancer[J]. Int J Mol Sci, 2017, 18(1):197.
[2] 郑荣寿, 孙可欣, 张思维, 等. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2019, 41(1):19-28.
[3] Reima H, Soplepmann J, Elme A, et al. Changes in the quality of care of colorectal cancer in Estonia: a population-based high-resolution study[J]. BMJ Open, 2020, 10(10):e035556.
[4] De Haas-Kock DF, Buijsen J, Pijls-Johannesma M, et al. Concomitant hyperthermia and radiation therapy for trea-ting locally advanced rectal cancer[J]. Cochrane Database Syst Rev, 2009, 3:CD006269.
[5] Huang CM, Huang MY, Ma CJ, et al. Neoadjuvant FOLFOX chemotherapy combined with radiotherapy followed by radical resection in patients with locally advanced colon cancer[J]. Radiat Oncol, 2017, 12(1):48.
[6] Dehal A, Graff-Baker AN, Vuong B, et al. Neoadjuvant chemotherapy improves survival in patients with clinical T4b colon cancer[J]. J Gastrointest Surg, 2018, 22(2):242-249.
[7] Karoui M, Rullier A, Luciani A, et al. Neoadjuvant FOLFOX 4 versus FOLFOX 4 with cetuximab versus immediate surgery for high-risk stage Ⅱ and Ⅲ colon cancers: a multicenter randomised controlled phase Ⅱ trial--the PRODIGE 22--ECKINOXE trial[J]. BMC Cancer, 2015, 15:511.
[8] Foxtrot Collaborative Group. Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomized controlled trial[J]. Lancet Oncol, 2012, 13(11):1152-1160.
[9] Liu F, Tong T, Huang D, et al. CapeOX perioperative chemotherapy versus postoperative chemotherapy for locally advanced resectable colon cancer: protocol for a two-period randomized controlled phase Ⅲ trial[J]. BMJ Open, 2019, 9(1):e017637.
[10] Dehal AN, Graff-Baker AN, Vuong B, et al. Correlation between clinical and pathologic staging in colon cancer: implications for neoadjuvant treatment[J]. J Gastrointest Surg, 2018, 22(10):1764-1771.
[11] Liu F, Yang L, Wu Y, et al. CapOX as neoadjuvant chemotherapy for locally advanced operable colon cancer patients: a prospective single-arm phase Ⅱ trial[J]. Chin J Cancer Res, 2016, 28(6):589-597.
[12] Jakobsen A, Andersen F, Fischer A, et al. Neoadjuvant chemotherapy in locally advanced colon cancer. a phase Ⅱ trial[J]. Acta Oncol, 2015, 54(10):1747-1753.
[13] Wu C. Systemic therapy for colon cancer[J]. Surg Oncol Clin N Am, 2018, 27(2):235-242.
[14] Chang H, Yu X, Xiao WW, et al. Neoadjuvant chemoradiotherapy followed by surgery in patients with unresectable locally advanced colon cancer: a prospective observational study[J]. Onco Targets Ther, 2018, 11:409-418.
[15] Tomizawa K, Miura Y, Fukui Y, et al. Curative resection for locally advanced sigmoid colon cancer using neoadjuvant chemotherapy with FOLFOX plus panitumumab: a case report[J]. Int J Surg Case Rep, 2017, 31:128-131.
[16] Arredondo J, Baixauli J, Pastor C, et al. Mid-term oncologic outcome of a novel approach for locally advanced colon cancer with neoadjuvant chemotherapy and surgery[J]. Clin Transl Oncol, 2017, 19(3):379-385.
[17] Hawkins AT, Ford MM, Geiger TM, et al. Neoadjuvant radiation for clinical T4 colon cancer: a potential improvement to overall survival[J]. Surgery, 2019, 165(2):469-475.
[18] Sekiya S, Imamura K, Takeuchi S, et al. Pathological complete response of locally advanced colon cancer after preoperative radiotherapy: a case report and narrative review of the literature[J]. Surg Case Rep, 201815, 4(1):58.
[19] Reibetanz J, Germer CT. Neoadjuvant chemotherapy for locally advanced colon cancer: initial results of the FOxTROT study[J]. Chirurg, 2013-10-13. [online ahead of print]
[20] Pellino G, Warren O, Mills S, et al. Comparison of Wes-tern and Asian guidelines concerning the management of colon cancer[J]. Dis Colon Rectum, 2018, 61(2):250-259.
[21] 李英杰, 武云龙, 崔健, 等. cT4N+期结肠癌新辅助化疗后外科治疗的效果和安全性[J]. 中华肿瘤杂志, 2019, 41(6):454-459.
[22] 彭俊杰, 朱骥, 刘方奇, 等. 中国局部进展期直肠癌诊疗专家共识[J]. 中国癌症杂志, 2017, 27(1):41-80.
[23] Meyers BM, Cosby R, Quereshy F, et al. Adjuvant chemotherapy for stage Ⅱ and Ⅲ colon cancer follo-wing complete resection: a cancer care ontario syste-matic review[J]. Clin Oncol, 2017, 29(7):459-465.
[24] Zhou H, Song Y, Jiang J, et al. A pilot phase Ⅱ study of neoadjuvant triplet chemotherapy regimen in patients with locally advanced resectable colon cancer[J]. Chin J Cancer Res, 2016, 28(6):598-605.
[25] Serrano PE, Carter DN, Li C, et al. Adjuvant chemothe-rapy with or without biologics including antiangiogenics and monoclonal antibodies targeting EGFR and EpCAM in colorectal cancer: a systematic review and meta-analysis[J]. J Surg Res, 2019, 239:14-21.
[26] Wiegering A, Kunz M, Hussein M, et al. Diagnostic value of preoperative CT scan to stratify colon cancer for neoadjuvant therapy[J]. Int J Colorectal Dis, 2015, 30(8):1067-1073.
[27] Venigalla S, Chowdhry AK, Wojcieszynski AP, et al. Comparative effectiveness of neoadjuvant chemoradiation versus upfront surgery in the management of recto-sigmoid junction cancer[J]. Clin Colorectal Cancer, 2018, 17(3):e557-e568.
[28] Cheong CK, Nistala KRY, Ng CH, et al. Neoadjuvant therapy in locally advanced colon cancer: a meta-analysis and systematic review[J]. J Gastrointest Oncol, 2020, 11(5):847-857.
[29] 杨晓东, 刘弋. 基于循证医学的结肠癌新辅助化疗[J]. 中华胃肠外科杂志, 2014, 17(11):1151-1155.
[30] Ahmed S, Johnson K, Ahmed O, et al. Advances in the management of colorectal cancer: from biology to treatment[J]. Int J Colorectal Dis, 2014, 29(9):1031-1042.
[31] Ceelen W, van Nieuwenhove Y, Putte DV, et al. Neoadjuvant chemotherapy with bevacizumab may improve outcome after cytoreduction and hyperthermic intraperitoneal chemoperfusion (HIPEC) for colorectal carcinomatosis[J]. Ann Surg Oncol, 2014, 21(9):3023-3028.
[32] Huang L, Li TJ, Zhang JW, et al. Neoadjuvant chemothe-rapy followed by surgery versus surgery alone for colorec-tal cancer: meta-analysis of randomized controlled trials[J]. Medicine (Baltimore), 2014, 93(28):e231.
[33] Krishnamurty DM, Hawkins AT, Wells KO, et al. Neoadjuvant radiation therapy in locally advanced colon cancer: a cohort analysis[J]. J Gastrointest Surg, 2018, 22(5):906-912.
[34] Klaver CE, Gietelink L, Bemelman WA, et al. Dutch surgical colorectal audit group. locally advanced colon cancer: evaluation of current clinical practice and treatment outcomes at the population level[J]. J Natl Compr Canc Netw, 2017, 15(2):181-190.
[35] Musiienko AM, Alzahrani S, Simpson JAD, et al. Pre-operative chemoradiation for an ascending colon tumour: novel approach to achieve a complete resection[J]. ANZ J Surg, 2018, 88(4):E342-E344.
[36] Nishikawa T, Ishihara S, Emoto S, et al. Multivisceral resections for locally advanced colorectal cancer after preoperative treatment[J]. Mol Clin Oncol, 2018, 8(3):493-498.
[37] Qiu B, Ding PR, Cai L, et al. Outcomes of preoperative chemoradiotherapy followed by surgery in patients with unresectable locally advanced sigmoid colon cancer[J]. Chin J Cancer, 2016, 35(1):65.
[38] Hallet J, Zih FS, Lemke M, et al. Neo-adjuvant chemoradiotherapy and multivisceral resection to optimize R0 resection of locally recurrent adherent colon cancer[J]. Eur J Surg Oncol, 2014, 40(6):706-712.
[39] Zhou J, Guo Z, Yu W, et al. Clinical evaluation of pre-operative radiotherapy combined with FOLFOX chemothe-rapy on patients with locally advanced colon cancer[J]. Am Surg, 2019, 85(4):313-320.
[40] Choi JH, Kim JH, Moon W, et al. Is it possible to successfully treat locally advanced colon cancer using pre-operative chemoradiotherapy?[J]. Clin Endosc, 2019, 52(2):191-195.
Options
文章导航

/

〈 〉